LENZ THERAPEUTICS, INC. Restricted Cash
LENZ THERAPEUTICS, INC. (LENZ) had Restricted Cash of $100.00 thousand as of 2023-12-31, per its 10-K filed 2024-02-27.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCash · last filed 2024-02-27
- 2023-12-31: Restricted Cash $100.00K.
- 2023-09-30: Restricted Cash $1.70M.
- 2023-06-30: Restricted Cash $1.70M.
- 2023-03-31: Restricted Cash $1.70M.
| Period end | Restricted Cash | Restricted Cash as first filed |
|---|---|---|
| 2023-12-31 | $100.00K 10-K · filed 2024-02-27 | |
| 2023-09-30 | $1.70M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.70M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.70M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.70M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $1.70 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.72K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.72K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.70M 10-K · filed 2023-03-20 | $1.72M 10-K · filed 2022-03-21 |
| 2020-12-31 | $35.00K 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |